The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Implications of COVID-19 for patients with pre-existing digestive diseases
Open accessAbstract
www.thelancet.com/gastrohep Vol 5 May 2020 425 histological review; therefore, the absence of observed association of CRC in patients with ileocolonic disease location should be interpreted with caution. Patients without defined extent were categorised with patients with L3 (ileocecal extent), according to the Montreal Classification. Although the Montreal Classification is the standard classification for Crohn’s disease distribution in research studies, it does not differentiate the extent of colonic inflammation very well. Thus, I would not interpret this observation as patients with ileocolonic Crohn’s disease not being at risk for CRC. As long as current guideline recommendations have to rely on scant data, I would still include patients with ileocolonic Crohn’s disease and involvement of at least a third of the colon in CRC colonoscopy surveillance regimens. HRs of CRC-associated mortality numerically increased in more recent time periods, between 2003–17. Why was this occurring? It should be noted that the data sources were not consistent during all study periods, with only inpatient data available for earlier time periods (until 2001 in Sweden and 1995 in Denmark), which makes comparisons between time periods difficult. The most recent 2003–17 study period included the early biologic era as well as an early era for colonoscopy surveillance; the absence of reduction in incidence and mortality of Crohn’s disease-associated CRC despite improvements in management of Crohn’s disease is disappointing. This observation might imply a longer time period of followup is needed for improved mucosal inflammation to result in reduction in CRC risk; additional temporal CRC trends in Crohn’s disease will need to be studied. Likewise, the effect of colonoscopy surveillance in patients with Crohn’s disease, which only occurred towards the end of the study period, will have to be studied further. This study highlights the subgroup with the highest HR of CRC mortality are patients diagnosed with Crohn’s disease before the age of 40 years, compared with the age-stratified reference population. However, the highest absolute risk of CRC mortality remains among patients over 60 years of age. Despite society guidelines to advocate colonoscopy surveillance in patients with ulcerative colitis and Crohn’s disease, rates of colonoscopy surveillance even among high-risk patients with ulcerative colitis and primary sclerosing cholangitis remain abysmal. Health-care providers need to better communicate risk of CRC to patients with Crohn’s disease, and remove barriers to colonoscopy surveillance for patients at risk. Clinical researchers need to further refine their ability to stratify patients most likely to benefit from surveillance resources required for colonoscopy surveillance. To do so, they need more precise means of analysing the extent of Crohn’s disease, and they need to identify optimal colonoscopy surveillance intervals, which are currently still undefined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Liver injury in COVID-19: management and challenges
Zhang, C., Shi, L., & Wang, F.-S. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30057-1 · Cited by 1,906
Kumar, D., Tellier, R., Draker, R., Levy, G. A., & Humar, A. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00197.x · Cited by 138
Cited by
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900
Tian, J., Yuan, X., Xiao, J., Zhong, Q., Yang, C., Liu, B., Cai, Y., Lu, Z., Wang, J., Wang, Y., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30309-0 · Cited by 528
Gong, D., Wu, L., Zhang, J., Mu, G., Shen, L., Liu, J., Wang, Z., Zhou, W., An, P., Huang, X., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30413-3 · Cited by 393
New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Zhang, Y., Geng, X., Tan, Y., Li, Q., Xu, C., Xu, J., Hao, L., Zeng, Z., Luo, X., Liu, F., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110195 · Cited by 319
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease
Li, J., & Fan, J.-G. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00019 · Cited by 318
Metadata
- Authors
- Mao, R., Liang, J., Shen, J., Ghosh, S., Zhu, L.-R., Yang, H., Wu, K.-C., & Chen, M.-H.
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 5
- Issue
- 5
- Pages
- 425-427
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- OpenAlex
- W3009928515
- Cited by
- 326
- References
- 5
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implications of COVID-19 for patients with pre-existing digestive diseases. https://app.cochat.ai/papers/10.1016/s2468-1253(20)30076-5
- The paper
- Mao, R., Liang, J., Shen, J., Ghosh, S., Zhu, L.-R., Yang, H., Wu, K.-C., & Chen, M.-H. (2020). Implications of COVID-19 for patients with pre-existing digestive diseases. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(20)30076-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.